360 related articles for article (PubMed ID: 27155363)
1. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
2. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
Maity AR; Stepensky D
Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
[TBL] [Abstract][Full Text] [Related]
3. Intracellular delivery of nanocarriers and targeting to subcellular organelles.
Jhaveri A; Torchilin V
Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656
[TBL] [Abstract][Full Text] [Related]
4. Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics.
Liew SS; Qin X; Zhou J; Li L; Huang W; Yao SQ
Angew Chem Int Ed Engl; 2021 Feb; 60(5):2232-2256. PubMed ID: 32128948
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review.
Rathore B; Sunwoo K; Jangili P; Kim J; Kim JH; Huang M; Xiong J; Sharma A; Yang Z; Qu J; Kim JS
Biomaterials; 2019 Aug; 211():25-47. PubMed ID: 31078050
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics.
Pan L; Liu J; Shi J
Chem Soc Rev; 2018 Sep; 47(18):6930-6946. PubMed ID: 30062349
[TBL] [Abstract][Full Text] [Related]
7. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
Singh D
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38303531
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.
Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA
Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
10. Intracellular organelle-targeted non-viral gene delivery systems.
Won YW; Lim KS; Kim YH
J Control Release; 2011 May; 152(1):99-109. PubMed ID: 21255626
[TBL] [Abstract][Full Text] [Related]
11. Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery.
Li Q; Zhou T; Wu F; Li N; Wang R; Zhao Q; Ma YM; Zhang JQ; Ma BL
Drug Metab Rev; 2018 Nov; 50(4):430-447. PubMed ID: 30270675
[TBL] [Abstract][Full Text] [Related]
12. Delivery of drugs to intracellular organelles using drug delivery systems: Analysis of research trends and targeting efficiencies.
Maity AR; Stepensky D
Int J Pharm; 2015 Dec; 496(2):268-74. PubMed ID: 26516100
[TBL] [Abstract][Full Text] [Related]
13. 'IntraCell' plugin for assessment of intracellular localization of nano-delivery systems and their targeting to the individual organelles.
Sneh-Edri H; Stepensky D
Biochem Biophys Res Commun; 2011 Feb; 405(2):228-33. PubMed ID: 21219848
[TBL] [Abstract][Full Text] [Related]
14. In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy.
Li Z; Zou J; Chen X
Adv Mater; 2023 May; 35(21):e2209529. PubMed ID: 36445169
[TBL] [Abstract][Full Text] [Related]
15. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
Torchilin VP
Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
[TBL] [Abstract][Full Text] [Related]
16. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?
Field LD; Delehanty JB; Chen Y; Medintz IL
Acc Chem Res; 2015 May; 48(5):1380-90. PubMed ID: 25853734
[TBL] [Abstract][Full Text] [Related]
17. Nanomaterials: impact on cells and cell organelles.
Krpetić Z; Anguissola S; Garry D; Kelly PM; Dawson KA
Adv Exp Med Biol; 2014; 811():135-56. PubMed ID: 24683031
[TBL] [Abstract][Full Text] [Related]
18. Organelle targeting: third level of drug targeting.
Sakhrani NM; Padh H
Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides with intracellular organelle targeting.
Cerrato CP; Künnapuu K; Langel Ü
Expert Opin Drug Deliv; 2017 Feb; 14(2):245-255. PubMed ID: 27426871
[TBL] [Abstract][Full Text] [Related]
20. Nanopreparations for organelle-specific delivery in cancer.
Biswas S; Torchilin VP
Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
